CASP3 and Thrombocytopenia: In 2006, Leytin and colleagues reported that anti-GPIIb antibody injection in mice induced thrombocytopenia, platelet caspase-3 activation, enhanced phosphatidylserine (PS) exposure and mitochondrial inner transmembrane potential (ΔΨm) depolarisation.